Karus Therapeutics showcased in BVCA’s Britain’s Hot Talents 2014/15

Oxford, UK, February 2014 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, has been featured in the British Private Equity and Venture Capital Association (BVCA)’s handbook of venture capital innovation, Britain’s Hot Talent. In its third edition, Britain’s Hot Talent showcases venture capital in action, profiling over 100 of the most inventive, exciting and fastest-growing companies in the UK today. The book is a gallery of some of the best and brightest companies from all sectors, from cleantech to gaming, from online retail to film special effects. Karus was featured along 10 other companies in the Life Sciences sector.

To read the book click here.

For more information on Karus or for media enquiries, please contact karus@instinctif.com.